World Thrombosis Day Campaign Activates Global Awareness Efforts on Evidence- based Prevention of Blood Clots for Ninth Consecutive Year – THISDAYLIVE thisdaylive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thisdaylive.com Daily Mail and Mail on Sunday newspapers.
Award-Winning Global Campaign Heightens Efforts this Year to Share Patient and Survivor Stories to Highlight the Prevalence of Blood Clots-the Leading Cause of Preventable Deaths Worldwide CHAPEL
/PRNewswire/ Today is World Thrombosis Day, a global awareness campaign led by the International Society on Thrombosis and Haemostasis (ISTH), recognized.
Advertisement
Britons are cancelling appointments for the Oxford/AstraZeneca coronavirus vaccine amid fears over its potential link to rare brain clots, GPs warned today.
In what could be a major blow to vaccine uptake, doctors said they had been inundated with patients of all ages requesting to be given an alternative to the British-made jab.
GPs have also been bombarded with people complaining of headaches and requesting brain scans after getting their first dose.
The concerns come amid fears that public confidence in the jab has been eroded after regulators suspended its use in healthy under-30s yesterday while it continues to probe its link to blood clots. The clots have been spotted in just 79 out of 20million Brits vaccinated with the AstraZeneca jab.
Deaths involving coronavirus have plummeted 92% since the peak of the second wave in January, official weekly figures for England and Wales showed in the latest sign of progress against the pandemic.
Some 712 deaths involving Covid-19 happened in the seven days to March 19, according to the Office for National Statistics, down from 8,945 deaths in the week ending January 22 and the lowest level of weekly occurrences since October 9.
Meanwhile, the latest Public Health England (PHE) data showed Covid-19 case rates have dropped across all regions.
The positive indications came as ministers and health experts continued efforts to reassure the public about the safety of the Oxford/AstraZeneca vaccine after regulators pointed to a one in a million chance of dying from a rare blood clot.